Clinical practice guidelines for the management of atopic dermatitis 2018.
Norito KatohYukihiro OhyaMasanori IkedaTamotsu EbiharaIchiro KatayamaHidehisa SaekiNaoki ShimojoAkio TanakaTakeshi NakaharaMizuho NagaoMichihiro HideYuji FujitaTakao FujisawaMasaki FutamuraKoji MasudaHiroyuki MurotaKiwako Yamamoto-HanadaPublished in: The Journal of dermatology (2019)
Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.
Keyphrases
- atopic dermatitis
- clinical practice
- oxidative stress
- healthcare
- multiple sclerosis
- physical activity
- smoking cessation
- rheumatoid arthritis
- magnetic resonance imaging
- magnetic resonance
- hiv testing
- hepatitis c virus
- diffusion weighted imaging
- combination therapy
- men who have sex with men
- antiretroviral therapy
- human immunodeficiency virus
- hiv infected